Related Experiment Videos
Vaccine allergy and pseudo-allergy
Claude Ponvert1, Pierre Scheinmann
1Pediatric Pulmonology & Allergy Service, Sick Children Hospital, 149, rue de Sèvres, 75015-Paris, France. pneumo.allergo@nck.ap-hop-paris.fr
European Journal of Dermatology : EJD
|March 1, 2003
Summary
Allergic reactions to vaccines often manifest in the skin, ranging from localized reactions to systemic symptoms. Diagnostic approaches include skin tests and specific antibody measurements (IgE, IgM, IgG) to guide management and predict outcomes.
Area of Science:
- Immunology
- Dermatology
- Vaccinology
Background:
- Allergic and pseudo-allergic reactions to vaccines commonly present with cutaneous manifestations.
- These reactions can be localized at vaccination sites (e.g., nodules, granulomas) or systemic (e.g., urticaria, angioedema, serum sickness).
Purpose of the Study:
- To review the diagnostic approaches for allergic and pseudo-allergic reactions to vaccines.
- To discuss the utility of various immuno-allergological tests in identifying causative agents and guiding clinical management.
Main Methods:
- Review of clinical history and diagnostic criteria for Arthus-type reactions.
- Evaluation of skin tests (immediate and non-immediate responses) and specific antibody determinations (IgE, IgM, IgG).
- Assessment of diagnostic value of immuno-allergological tests for various vaccine components.
Main Results:
- Specific IgM/IgG anti-toxoid determination aids in diagnosing Arthus-type reactions.
- Skin tests and specific IgE have diagnostic value for anaphylaxis and immediate/accelerated urticaria/angioedema.
- Diagnosis of BCG-related dextran reactions relies on specific IgM/IgG levels; management involves withholding boosters if levels are high.
Conclusions:
- Diagnostic strategies for vaccine-induced allergic reactions vary based on reaction type and causative agent.
- Immuno-allergological testing plays a crucial role in diagnosis and management, including desensitization protocols for severe reactions.
- Careful consideration of diagnostic test results guides decisions on booster injections and desensitization procedures.